Peter Kolchinsky - Jun 17, 2021 Form 4 Insider Report for Forma Therapeutics Holdings, Inc. (FMTX)

Role: Director, 10%+ Owner
Signature: /s/ Jeannette Potts, as Attorney-in-Fact
Stock symbol: FMTX
Transactions as of: Jun 17, 2021
Transactions value $: $0
Form type: 4
Date filed: 6/21/2021, 07:01 PM
Next filing: Jun 24, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FMTX	Common Stock	Award	$0	+2.75K		$0.00	2.75K	Jun 17, 2021	Direct	F1, F2
holding	FMTX	Common Stock						9.01M	Jun 17, 2021	See footnote	F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FMTX	Stock Option (Right to Buy)	Award	$0	+8.38K		$0.00	8.38K	Jun 17, 2021	Common Stock	8.38K	$25.35	Direct	F2, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares represent restricted stock units and will be settled into common stock upon vesting. Each restricted stock unit would be converted into one share of FMTX common stock.
F2	Under the Reporting Person's arrangement with RA Capital Management, L.P. (the "Adviser"), the Reporting Person holds the option and restricted share units for the benefit of the RA Capital Healthcare Fund, L.P. (the "Fund") and RA Capital Nexus Fund, L.P. (the "Nexus Fund"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received upon sale of the common stock underlying the option and restricted share units, which will offset advisory fees owed by the Fund and the Nexus Fund to the Adviser. The Reporting Person therefore disclaims beneficial ownership of the option, restricted share units and the underlying common stock.
F3	Includes (a) 7,500,226 shares held by the Fund and (b) 1,511,425 shares held by the Nexus Fund.
F4	The Adviser is the investment manager for the Fund and the Nexus Fund. The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which the Reporting Person and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, the Reporting Person and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.
F5	This option shall vest and become exercisable in full upon the earlier to occur of (i) June 17, 2022 and (ii) the next annual meeting of the Issuer's stockholders.